Evidence map›Paper›PMID 42778727›Full record

ReviewNature reviews. Clinical oncology2026

Optimizing the delivery of radiotherapy with artificial intelligence.

Evangelia Katsoulakis, Issam El Naqa

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Evangelia KatsoulakisDepartment of Machine Learning, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Issam El NaqaDepartment of Machine Learning, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Issam.ElNaqa@moffitt.org.ORCID http://orcid.org/0000-0001-6023-1132

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) and machine learning are transformative technologies that have sparked both excitement and concern. In radiation oncology, AI has been successfully applied to automate tasks, such as auto-contouring, geometric adaptation, calculation of radiation dose and quality assurance, and predicting outcomes to provide optimal patient care. The clinical deployment of AI-driven and machine learning-based tools, however, continues to lag behind their perceived potentials, owing to a range of technical, practical, ethical and legal concerns. The original predictive AI algorithms have been expanded with technologies such as generative AI and foundation models to enable new applications, such as automated treatment planning and synthetic computed tomography generation, as well as improved prediction of individual patient outcomes. The increasing availability of innovations such as agentic AI, digital twins and multimodal AI could further improve the delivery and, thus, the efficacy of radiotherapy. In this Review, we present examples of successful AI applications in radiation oncology, provide an overview of the current challenges for implementing such tools in this specialty and strategies for addressing them, and discuss the broader implications of these tools in optimizing treatment outcomes and the quality of patient care.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.